Finance

Lists
AKUMS:NSE
Akums Drugs and Pharmaceuticals Ltd
₹ 776.00
+0.87%
(+6.70) 1D
10-р сарын 14, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AKUMS...
Open
₹ 773.95
High
₹ 776.00
Low
₹ 753.30
Mkt. cap
118.81Т
Avg. vol.
291.87 мян
Volume
134.29 мян
Dividend
0.13%
Quarterly dividend
₹ 0.25
Ex-dividend date
2026 оны 7-р сарын 3
P/E ratio
40.74
52-wk high
₹ 838.80
52-wk low
₹ 409.30
EPS
₹ 19.05
No. of employees
7 мян
Open
₹ 773.95
High
₹ 776.00
Low
₹ 753.30
Mkt. cap
118.81Т
Avg. vol.
291.87 мян
Volume
134.29 мян
Dividend
0.13%
Quarterly dividend
₹ 0.25
Ex-dividend date
2026 оны 7-р сарын 3
P/E ratio
40.74
52-wk high
₹ 838.80
52-wk low
₹ 409.30
EPS
₹ 19.05
No. of employees
7 мян
News stories
From web sources and news partners
Profile
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
About Akums Drugs and Pharmaceuticals Ltd
CEO-
Employees7.34 мян
Founded2004
Headquarters-
SectorHealth care
Websiteakums.in
Last report
2026 оны 8-р сарын 10
Fiscal period
Q1 2027
₹ 6.53 / ₹ 6.10
+7.05%beat
Revenue / Est. (INR)
11.67 тэрбум / 11.65 тэрбум
+0.14%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
10.18 тэрбум
11.60 тэрбум
11.60 тэрбум
11.67 тэрбум
Cost of goods sold
5.93 тэрбум
6.79 тэрбум
7.37 тэрбум
6.45 тэрбум
Cost of revenue
5.93 тэрбум
6.79 тэрбум
7.37 тэрбум
6.45 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.89 тэрбум
1.89 тэрбум
2.37 тэрбум
2.01 тэрбум
Operating expense
3.68 тэрбум
3.74 тэрбум
3.09 тэрбум
3.88 тэрбум
Total operating expenses
9.61 тэрбум
10.52 тэрбум
10.46 тэрбум
10.33 тэрбум
Operating income
566.12 сая
1.07 тэрбум
1.14 тэрбум
1.34 тэрбум
Other non operating income
323.65 сая
343.28 сая
-942.12 сая
303.80 сая
EBT including unusual items
656.73 сая
995.66 сая
1.21 тэрбум
1.39 тэрбум
EBT excluding unusual items
656.73 сая
1.18 тэрбум
1.19 тэрбум
1.39 тэрбум
Income tax expense
229.77 сая
318.92 сая
398.74 сая
382.59 сая
Effective tax rate
34.99%
32.03%
32.89%
27.48%
Other operating expenses
1.41 тэрбум
1.45 тэрбум
319.86 сая
1.45 тэрбум
Net income
407.83 сая
663.17 сая
846.13 сая
1.00 тэрбум
Net profit margin
4.01%
5.72%
7.29%
8.57%
Earnings per share
2.66
5.14
-
6.53
Interest and investment income
-
-
1.10 тэрбум
-
Interest expense
-233.04 сая
-237.42 сая
-184.41 сая
-247.56 сая
Net interest expenses
-233.04 сая
-237.42 сая
912.36 сая
-247.56 сая
Depreciation and amortization charges
378.64 сая
396.49 сая
401.18 сая
410.65 сая
EBITDA
940.04 сая
1.42 тэрбум
1.49 тэрбум
1.69 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс